OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 2

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 25.8% 659,183 2,558,164 25.5% 0.3%
Sex Female 27.7% 410,935 1,481,438 27.4% 0.3%
Male 23.1% 248,248 1,076,726 22.8% 0.3%
Ethnicity White - British 25.5% 366,380 1,436,897 25.2% 0.3%
White - Irish 25.9% 5,397 20,874 25.5% 0.3%
White - Any other White background 24.5% 13,482 55,041 24.1% 0.4%
Mixed - White and Black Caribbean 29.8% 1,099 3,689 28.7% 1.1%
Mixed - White and Black African 21.6% 252 1,169 21.6% 0.0%
Mixed - White and Asian 24.1% 315 1,309 23.5% 0.5%
Mixed - Any other mixed background 25.7% 602 2,345 25.1% 0.6%
Asian or Asian British - Indian 24.1% 7,903 32,788 23.6% 0.5%
Asian or Asian British - Pakistani 32.2% 5,390 16,723 30.7% 1.5%
Asian or Asian British - Bangladeshi 34.1% 1,666 4,879 32.3% 1.9%
Asian or Asian British - Any other Asian background 24.9% 2,891 11,592 24.3% 0.6%
Black or Black British - Caribbean 30.7% 7,161 23,352 29.3% 1.4%
Black or Black British - African 25.6% 2,212 8,638 24.1% 1.5%
Black or Black British - Any other Black background 27.6% 693 2,513 26.5% 1.1%
Other ethnic groups - Chinese 23.7% 973 4,102 22.9% 0.9%
Other ethnic groups - Any other ethnic group 29.0% 1,981 6,832 28.3% 0.7%
Patients with any other ethnicity code 24.9% 98,490 395,367 24.6% 0.3%
Ethnicity not stated 28.9% 4,788 16,576 28.4% 0.5%
Ethnicity not recorded 26.8% 137,389 513,394 26.5% 0.3%
Ethnicity (broad categories) White 25.5% 385,273 1,512,819 25.2% 0.3%
Mixed 26.9% 2,296 8,526 26.0% 0.9%
South Asian 27.1% 17,864 66,003 26.2% 0.9%
Black 29.2% 10,087 34,517 27.8% 1.4%
Other 27.1% 2,961 10,941 26.2% 0.8%
Unknown 26.0% 240,681 925,337 25.7% 0.3%
Index of Multiple Deprivation 1 (most deprived) 26.4% 201,467 762,608 26.0% 0.4%
2 26.9% 94,255 350,371 26.5% 0.4%
3 26.2% 115,766 441,896 25.9% 0.3%
4 25.3% 120,582 477,372 25.0% 0.2%
5 (least deprived) 24.2% 122,367 506,184 24.0% 0.2%
Unknown 24.0% 4,732 19,719 23.7% 0.3%
Clinical Risk Groups Patients in Any Clinical Risk Group 26.7% 492,107 1,844,640 26.3% 0.3%
Patients with Immunosuppression 25.2% 27,888 110,747 24.9% 0.3%
Patients with CKD 27.3% 213,213 780,710 27.0% 0.3%
Patients who have Chronic Respiratory Disease 26.6% 81,529 306,635 26.3% 0.3%
Patients with Diabetes 27.0% 140,175 519,274 26.6% 0.4%
Patients with Chronic Liver disease 25.9% 12,054 46,606 25.5% 0.4%
Patients with CNS Disease (including Stroke/TIA) 31.1% 133,105 427,644 30.7% 0.4%
Patients with Chronic heart disease 27.0% 292,005 1,082,998 26.6% 0.3%
Patients with Asplenia or Dysfunction of the Spleen 24.4% 5,019 20,587 24.1% 0.2%
Patients with Wider Learning Disability 45.7% 595 1,302 44.6% 1.1%
Patients with Severe Mental Health 37.2% 6,475 17,402 36.4% 0.8%
Other Groups Patients who are shielding (High Risk from COVID-19) 29.9% 225,953 755,370 29.5% 0.4%
Patients with Morbid Obesity 34.4% 12,026 35,007 33.8% 0.5%
Patients who are pregnant 28.3% 91 322 26.1% 2.2%